Back to News
Market Impact: 0.2
Arcus Biosciences (RCUS) Shares Cross Below 200 DMA
Source: Nasdaq
Market Technicals & FlowsHealthcare & Biotech
Arcus Biosciences shares fell about 6% on Friday to as low as $24.32, breaking below their 200-day moving average of $24.72. The technical breakdown is a bearish signal for RCUS but is unlikely to have material broader market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
RCUS-0.45
More News
- Lula wins Brazil runoff after prediction markets favored Bolsonaro
- Brazil’s real sinks after Lula’s re-election victory
- One-Day Wipeout Tops 60% For the Hardest-Hit Brazilian Stocks
- Trump says Brazil election looked ’rigged’, defeated Bolsonaro’s party recognizes Lula win
- Japan Exchange Group H1 profit jumps 65% on soaring trading activity
- A shock in Brazil sends stocks plunging, while neoclouds take another hit